Invention Grant
US07390814B2 Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
有权
取代的六氢吡嗪并[1,2-a]嘧啶-4,7-二酮衍生物,其制备方法和用作药物
- Patent Title: Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
- Patent Title (中): 取代的六氢吡嗪并[1,2-a]嘧啶-4,7-二酮衍生物,其制备方法和用作药物
-
Application No.: US10778554Application Date: 2004-02-13
-
Publication No.: US07390814B2Publication Date: 2008-06-24
- Inventor: Stefanie Flohr , Siegfried Stengelin , Matthias Gossel , Thomas Klabunde , Pavel Safar , James Spoonamore , Martin Smrcina
- Applicant: Stefanie Flohr , Siegfried Stengelin , Matthias Gossel , Thomas Klabunde , Pavel Safar , James Spoonamore , Martin Smrcina
- Applicant Address: DE Frankfurt
- Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee Address: DE Frankfurt
- Agent Barbara E. Kurys
- Main IPC: A01N43/90
- IPC: A01N43/90 ; C07D239/70
![Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments](/abs-image/US/2008/06/24/US07390814B2/abs.jpg.150x150.jpg)
Abstract:
Substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicamentsThe invention relates to substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof.Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and processes for preparing them are described. The compounds are suitable for example as anorectic agents.
Public/Granted literature
Information query
IPC分类: